XML 61 R22.htm IDEA: XBRL DOCUMENT v2.4.1.9
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Mar. 31, 2015
Accounting Policies [Abstract]  
Summary of Stock-Based Compensation Expense of Stock Options and Restricted Stock Units
The following tables summarize the allocation of the stock-based compensation expense (in thousands):
 
 
Fiscal Years Ended March 31,
 
2015
 
2014
 
2013
Stock-based compensation expense by type of grant:
 
 
 
 
 
Option grants and employee stock purchase rights
$
1,408

 
$
2,520

 
$
3,469

Restricted stock units
16,892

 
14,517

 
20,620

 
18,300

 
17,037

 
24,089

Stock-based compensation expensed from (capitalized to) inventory
5

 
(16
)
 
147

Total stock-based compensation expense
$
18,305

 
$
17,021

 
$
24,236

Summary of Stock-Based Compensation Expense
 
Fiscal Years Ended March 31,
 
2015
 
2014
 
2013
Stock-based compensation expense by cost centers:
 
 
 
 
 
Cost of revenues
$
285

 
$
460

 
$
545

Research and development
11,657

 
6,371

 
11,760

Selling, general and administrative
6,358

 
10,206

 
11,784

 
18,300

 
17,037

 
24,089

Stock-based compensation expensed from (capitalized to) inventory
5

 
(16
)
 
147

Total stock-based compensation expense
$
18,305

 
$
17,021

 
$
24,236

Schedule of Weighted-Average Assumptions Used to Estimate the Fair Value of Stock Options
The fair values of the options and employee stock purchase rights granted are estimated as of the grant date using the Black-Scholes option-pricing model with the following weighted-average assumptions:
 
 
Options
 
Employee Stock Purchase Rights
 
Fiscal Years Ended March 31,
 
Fiscal Years Ended March 31,
 
2015
 
2014
 
2013
 
2015
 
2014
 
2013
Expected life (years)
*
 
4.4

 
4.4

 
0.5

 
0.5

 
0.5

Risk-free interest rate
*
 
0.6
%
 
0.7
%
 
0.1
%
 
%
 
%
Volatility
*
 
0.49

 
0.54

 
0.57

 
0.56

 
0.50

Dividend yield
*
 
%
 
%
 
%
 
%
 
%
Expected forfeiture rate
*
 
5.8
%
 
6.6
%
 
%
 
%
 
%
Weighted average fair value
*
 
$
2.95

 
$
2.47

 
$
2.17

 
$
3.40

 
$
1.77



* The Company did not grant options during the twelve months ended March 31, 2015.